Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$26.30 +0.40 (+1.53%)
As of 02:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PNTG vs. SHC, PRVA, CON, SGRY, ADUS, VCYT, PACS, WGS, LFST, and ARDT

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), Veracyte (VCYT), PACS Group (PACS), GeneDx (WGS), LifeStance Health Group (LFST), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry.

The Pennant Group vs. Its Competitors

Sotera Health (NASDAQ:SHC) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Sotera Health presently has a consensus price target of $16.00, indicating a potential upside of 36.23%. The Pennant Group has a consensus price target of $34.60, indicating a potential upside of 31.58%. Given Sotera Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Sotera Health is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

The Pennant Group has a net margin of 3.40% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health2.24% 41.08% 5.68%
The Pennant Group 3.40%10.73%4.00%

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.11B3.01$44.34M$0.08146.81
The Pennant Group$695.24M1.30$22.56M$0.7634.60

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 47.5% of Sotera Health shares are owned by insiders. Comparatively, 5.4% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, The Pennant Group had 2 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for The Pennant Group and 3 mentions for Sotera Health. The Pennant Group's average media sentiment score of 0.81 beat Sotera Health's score of 0.25 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
The Pennant Group
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500.

Summary

Sotera Health beats The Pennant Group on 12 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$906.39M$3.91B$5.49B$9.01B
Dividend YieldN/A1.27%5.39%4.09%
P/E Ratio34.6035.6227.4320.06
Price / Sales1.3096.91398.25108.31
Price / Cash29.3124.6336.1356.90
Price / Book2.904.398.085.67
Net Income$22.56M$189.47M$3.16B$248.47M
7 Day Performance-9.61%-2.94%2.12%2.90%
1 Month Performance-9.55%-3.93%4.43%5.75%
1 Year Performance8.08%8.45%35.62%21.36%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.7219 of 5 stars
$26.30
+1.5%
$34.60
+31.6%
+5.8%$906.39M$695.24M34.607,000News Coverage
SHC
Sotera Health
2.9797 of 5 stars
$11.09
-2.6%
$15.80
+42.5%
+0.1%$3.23B$1.10B138.643,000
PRVA
Privia Health Group
4.1449 of 5 stars
$21.61
-1.1%
$27.77
+28.5%
+27.7%$2.66B$1.74B180.101,140News Coverage
CON
Concentra Group Holdings Parent
3.3833 of 5 stars
$20.95
+1.0%
$28.50
+36.0%
N/A$2.66B$1.90B15.6311,250
SGRY
Surgery Partners
2.5973 of 5 stars
$20.20
+4.7%
$33.56
+66.1%
-7.2%$2.47B$3.11B-13.2015,000
ADUS
Addus HomeCare
4.9679 of 5 stars
$113.01
-0.7%
$142.57
+26.2%
-5.4%$2.09B$1.15B25.5149,703
VCYT
Veracyte
3.6596 of 5 stars
$26.71
+1.2%
$40.90
+53.1%
+29.7%$2.07B$445.76M65.15790
PACS
PACS Group
2.7792 of 5 stars
$12.77
-3.1%
$34.29
+168.5%
-56.1%$2.01B$3.11B0.0032,433
WGS
GeneDx
2.216 of 5 stars
$79.71
+19.0%
$86.75
+8.8%
+223.5%$1.91B$305.45M-56.531,200Analyst Forecast
Insider Trade
Gap Down
High Trading Volume
LFST
LifeStance Health Group
2.601 of 5 stars
$4.96
+2.7%
$8.50
+71.4%
-5.5%$1.88B$1.25B-49.6010,218News Coverage
ARDT
Ardent Health
3.4997 of 5 stars
$12.94
-0.8%
$20.67
+59.7%
N/A$1.87B$5.97B7.9424,900News Coverage

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners